首页> 美国卫生研究院文献>Cancer Science >Enhanced Tumor Localization of Radiolabeled Fab Fragments of Monoclonal Antibody A7 in Nude Mice Bearing Human Pancreatic Carcinoma Xenografts
【2h】

Enhanced Tumor Localization of Radiolabeled Fab Fragments of Monoclonal Antibody A7 in Nude Mice Bearing Human Pancreatic Carcinoma Xenografts

机译:单克隆抗体A7放射性标记的Fab片段在人胰腺癌异种移植裸鼠中的增强的肿瘤定位

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Much recent research has been directed toward the use of monoclonal antibodies (MAb) for the inimunodetection of solid tumors. In pancreatic cancer, the results of conventional immunoscintigraphy using intact MAb remain disappointing. Clear immunoseintigrapliy with radiolabeled MAb requires a high tumor tissue/blood ratio of radioactivity and a low normal tissue/blood ratio of radioactivity. In this study, 125I‐labeled Fab fragments produced by papain digestion of MAb A7 were injected intravenously into nude mice bearing a human pancreatic cancer (HPC‐YS) xenograft previously shown to react specifically with MAb A7. The radioactivity of tumors and normal organs was subsequently measured. The tumor tissue/blood ratio of 125I‐labeled Fab fragments of MAb A7 was 1.00±0.24 and 9.68±2.54 at 2 and 24 h after injection, respectively. The tumor tissue/blood ratio of radioactivity was significantly higher than those of normal organs at 24 h after injection. Moreover, the tumor tissue/blood ratio of 125I‐labeled Fab fragments of MAb A7 was greater than that of intact MAb A7, although the 125I‐labeled Fab accumulation level was much less than that of 125I‐labeled intact MAb A7 in the tumor. When mice bearing tumors which did not react with MAb A7 were studied, 125I‐labeled Fab fragments did not specifically localize to the tumors. These results suggest that Fab fragments of MAb A7 may be suitable carriers of radionuclides for the immunodetection of human pancreatic cancer.
机译:最近的许多研究都针对使用单克隆抗体(MAb)进行实体瘤的免疫检测。在胰腺癌中,使用完整单克隆抗体的常规免疫闪烁扫描结果仍然令人失望。用放射性标记的单克隆抗体进行清晰的免疫原发检查需要高的肿瘤组织/血液放射性比和低的正常组织/血液放射性比。在这项研究中,将木瓜蛋白酶消化MAb A7产生的 125 I标记的Fab片段静脉内注射到带有人胰腺癌(HPC-YS)异种移植物的裸鼠中,该裸鼠先前显示与MAb A7特异性反应。随后测量了肿瘤和正常器官的放射性。注射后2小时和24小时, 125 I标记的MAb A7的Fab片段的肿瘤组织/血液比率分别为1.00±0.24和9.68±2.54。注射后24 h,肿瘤组织/血液放射性比值明显高于正常器官。此外,尽管 125 I-标记的Fab积累水平, 125 I-标记的Fab Fab片段的肿瘤组织/血液比率大于完整的MAb A7。远小于肿瘤中 125 I标记的完整MAb A7的水平。当研究带有不与MAb A7反应的肿瘤的小鼠时, 125 I标记的Fab片段没有特异性地定位于肿瘤。这些结果表明,MAb A7的Fab片段可能是放射性核素的合适载体,用于免疫检测人胰腺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号